# FDA Inspection 1022265 - Reckitt Benckiser, LLC - August 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/8a45f5e7-9282-42f2-aad5-5db2d528bba0
Source feed: FDA_Inspections

> FDA Inspection 1022265 for Reckitt Benckiser, LLC on August 17, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022265
- Company Name: Reckitt Benckiser, LLC
- Inspection Date: 2017-08-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 971963 - 2016-05-12](https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/edf5233b-f096-4065-a369-840334a67ac6)
- [FDA Inspection 971963 - 2016-05-12](https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/92ad72c7-3273-4ae2-8f50-f5c1a788299d)
- [FDA Inspection 781026 - 2012-05-10](https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/b47e83b1-464e-4484-b1c2-32e4fe8ec639)
- [FDA Inspection 781026 - 2012-05-10](https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/15ba1fa8-8d0f-4c66-8c0e-50eeb38890c2)

Company: https://www.keypedia.com/companies/reckitt-benckiser-llc/4f471f82-3819-4e12-ba3e-242a71816938

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c